CL or PG or UL

Key Takeaways

• All three consumer staples giants face a challenging macro environment marked by sluggish category growth, value-conscious consumers, and persistent cost pressures — but their strategic responses and relative positioning diverge meaningfully.
• PG remains the revenue colossus at roughly $84 billion in annual sales and returned over $16 billion to shareholders in its latest fiscal year, yet organic sales growth has decelerated and the stock has underperformed the broader market.
• CL commands dominant oral care market share — 41.3% globally in toothpaste — but is navigating the exit from private-label pet food and absorbing significant impairment charges in its skin health segment.
• UL delivered the strongest total shareholder return among the three in 2025, rising approximately 11.6%, driven by operational restructuring and portfolio streamlining under its Growth Action Plan.
• Valuation dispersion is modest but notable — PG trades at a forward P/E (price-to-earnings ratio) near 20.8x, CL around 20.7x, and UL near 22.5x, reflecting differing growth expectations and geographic exposure profiles.
• Dividend reliability remains a unifying strength — all three companies have multi-decade track records of consistent dividend payments, reinforcing their appeal to income-oriented investors.

Introduction

Consumer staples stocks are often treated as a monolithic category by generalist investors, yet the divergence in strategy, geographic footprint, and recent performance among CL, PG, and UL is substantial. All three rank among the world's largest household and personal care companies, but their growth trajectories, margin profiles, and market sentiment have followed distinctly different paths. This comparison is particularly relevant for investors seeking to understand how brand strength, category exposure, and capital allocation discipline shape relative performance in an environment of moderating inflation, shifting consumer preferences, and uneven global demand. Whether the goal is dividend income, defensive positioning, or identifying relative value within the sector, examining these three bellwethers side by side provides a useful lens.

CL Overview and Recent Performance

Colgate-Palmolive (CL) is a global leader in oral care, personal care, home care, and pet nutrition, with its toothpaste and manual toothbrush franchises holding commanding global market share of approximately 41.3% and 32.4% respectively. In its most recent fiscal year, the company generated net sales of roughly $20.4 billion, reflecting organic sales growth (a measure that strips out currency swings and acquisition effects) of 1.4%. Base Business EPS (earnings per share excluding one-time items) increased 3% to $3.69, while GAAP (Generally Accepted Accounting Principles) EPS was heavily impacted by goodwill and intangible asset impairment charges tied to the skin health business. Gross profit margin held near 60%, though margin compression of roughly 40 basis points (0.40 percentage points) over the year reflected ongoing input cost headwinds. The company generated a record $4.2 billion in operating cash flow and returned $2.9 billion to shareholders through dividends and buybacks. Recent quarters have seen a strategic pivot: the company exited its private-label pet food operations — a non-core, lower-margin business — and launched a new 2030 strategy emphasizing science-based innovation, data analytics, and AI (artificial intelligence)-driven demand generation. The stock ended 2025 down roughly 13%, though it has recovered modest ground in early 2026 as management's confidence in accelerating growth has resonated with some investors.

PG Overview and Recent Performance

Procter & Gamble (PG) is the largest consumer packaged goods company in the world by revenue, with fiscal-year sales of approximately $84.3 billion spanning categories such as fabric care, baby care, feminine care, grooming, oral care, and home care. Organic sales in the most recent fiscal year grew 2%, with pricing contributing one point and organic volume contributing another. Diluted EPS rose 8% to $6.51, while Core EPS (adjusted for restructuring and impairment items) advanced 4% to $6.83. The company generated $17.8 billion in operating cash flow and returned over $16 billion to shareholders — $9.9 billion in dividends and $6.5 billion in share repurchases — marking the 69th consecutive year of dividend increases. Despite these operational strengths, PG's stock faced meaningful headwinds in 2025, declining roughly 12% as investors weighed slowing category consumption, rising promotional intensity in key markets such as North America and Europe, and the transitional costs of a large-scale restructuring program that aims to eliminate up to 7,000 non-manufacturing roles. The company's "Supply Chain 3.0" initiative targets $1.5 billion in cost savings over time, though near-term execution risks and tariff exposure have kept sentiment cautious. In recent months, the stock has traded below both its 50-day and 200-day moving averages, signaling bearish technical momentum.

UL Overview and Recent Performance

Unilever (UL), the Anglo-Dutch consumer goods giant, operates across beauty and wellbeing, personal care, home care, nutrition, and ice cream categories, with annual revenue of approximately €57 billion. Its brand portfolio includes Dove, Knorr, Hellmann's, Ben & Jerry's, and Rexona, among many others. In its most recent fiscal year, revenue grew modestly by 0.4%, reflecting a mixed demand environment across developed and emerging markets. Diluted EPS remained essentially flat year-over-year. What sets UL apart from its peers in recent market activity has been its stock performance: the company delivered a total return of roughly 11.6% in 2025, outperforming both CL and PG by a wide margin. This relative strength reflects investor confidence in the company's ongoing restructuring under its Growth Action Plan, which includes a separation of the ice cream business, a leaner operating model, and sharper capital allocation. The stock also benefited from strong prior-year momentum, having gained approximately 21% in 2024. However, UL has faced some reversal in early 2026, with shares pulling back modestly as broader consumer staples sentiment weakened and questions about the pace of margin recovery emerged. The company's dividend yield has remained competitive, recently hovering near 3.8%.

Trending AI Robots

For investors seeking a data-driven edge in evaluating stocks like CL, PG, and UL, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to navigate dynamic market conditions. Tickeron hosts hundreds of AI trading bots that collectively trade thousands of different tickers across equities, ETFs (exchange-traded funds), and crypto, but only those demonstrating the strongest alignment with prevailing market conditions earn a place in the Trending AI Robots section. These bots employ a wide range of trading styles — from short-term swing trading to longer-duration trend-following strategies — and their performance statistics, including win rates, annualized returns, and drawdown metrics, vary substantially based on strategy, timeframe, and underlying ticker selection. Each bot is purpose-built with a distinct algorithm, risk profile, and set of traded instruments, allowing users to compare approaches and identify those that match their own risk tolerance and investment objectives. Explore the Trending AI Robots to discover which automated strategies are currently resonating with the market's rhythm.

Head-to-Head Comparison

When comparing CL, PG, and UL across key dimensions, several contrasts come into focus. On scale, PG is by far the largest — its $84 billion revenue base is roughly four times that of CL and significantly larger than UL's — which provides pricing power and distribution advantages but also makes it harder to generate outsized growth. CL, by contrast, benefits from hyper-concentrated market leadership in oral care, a category where brand loyalty and dentist recommendations create formidable barriers to entry, though the company's narrower category exposure also concentrates its risk profile. UL sits between the two in terms of category breadth, with a particularly strong emerging-market footprint that provides higher growth potential but also greater foreign-exchange sensitivity.

On recent momentum, UL stands out: the stock's double-digit total return in 2025 sharply contrasted with the negative annual returns posted by both CL and PG. However, UL's EPS growth has been essentially stagnant, raising questions about whether the share price appreciation has been driven more by multiple expansion than by fundamental improvement. PG's organic sales growth of 2% has been steady but unspectacular, and the company's ongoing restructuring — while strategically sound — introduces near-term operational complexity. CL's exit from private-label pet food removes a drag on margins but also reduces reported revenue growth in the short term, though Base Business earnings continue to trend higher.

From a valuation standpoint, all three stocks trade at forward P/E multiples in the 20-23x range, with UL at the higher end despite its flatter EPS profile — potentially reflecting optimism about the ice cream separation unlocking shareholder value. Dividend reliability is a shared strength: PG has increased its dividend for 69 consecutive years, CL for decades, and UL also maintains a strong payout tradition, with current yields ranging from roughly 2.4% (CL) to approximately 3.8% (UL). Risk factors differ meaningfully as well: PG and CL face tariff exposure and U.S. consumer softness, while UL's European and emerging-market tilt exposes it to currency volatility and geopolitical complexity.

Tickeron AI Verdict

Based on observable trend consistency, relative momentum, and catalyst visibility, Tickeron's AI analysis would likely tilt most favorably toward UL in the current environment. The stock's superior total return profile across both 2024 and 2025, combined with a clearly defined corporate restructuring catalyst — the planned separation of the ice cream business — and a leaner operating model under the Growth Action Plan, offers the kind of trend persistence and event-driven upside that quantitative models tend to favor. CL presents the next most compelling case, with its dominant oral care franchise, improving post-restructuring earnings quality, and a newly articulated long-term strategy that could support a re-rating if execution proves consistent; however, the impairment charges and margin compression introduce noise that trend-following algorithms may penalize. PG, while the most financially robust company of the three in absolute terms, currently faces the stiffest near-term headwinds from promotional intensity, restructuring disruption, and negative technical momentum — factors that would likely temper AI-driven conviction until clearer evidence of a stabilization or reversal emerges. These assessments reflect probabilistic, pattern-based analysis rather than definitive predictions, and market conditions can shift rapidly.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations